Merck naming troubles continue

Share this article:

Same-name problems continue to plague US-based and Germany-based Mercks. Bloomberg reports that while confusion has been an ongoing concern since the companies split in the early 20th century, a recent protest by the StopAIDS group is further proof that a different home base is not enough for activists to go on.

The latest problem is that activists protested the German Merck, known as Merck KGaA, in front of which they pitched a complaint against its move to block low-cost copies of patented drugs from flowing into South Africa, but the company that is actually involved is the Merck which has headquarters in New Jersey.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Massachusetts painkiller ban overruled

A District Court says Massachusetts cannot ban opioid painkiller Zohydro.

Ranbaxy extends branded Diovan's life

Ranbaxy may be on the blocks, but it has a hold on the right to produce generics of the Novartis heart medication Diovan. Only problem: it can't, and that is good news for Novartis.

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.